eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-VERV-Verve Therapeutics Inc

Verve Therapeutics Inc VERV

4.480.26(6.16%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Verve Therapeutics Inc
Today
Create an eToro account to buy VERV stock on a secure, user-friendly, multi-asset trading platform.
Buy Verve Therapeutics Inc
Buy Verve Therapeutics Inc
Verve Therapeutics Inc VERV
Buy VERV
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
30.33
Based on analysts who covered VERV

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Verve Therapeutics Inc News

Why Verve Therapeutics Zoomed 40% Higher This Week
The Motley Fool • 18.04.25 • 22:36
Why Verve Therapeutics Zoomed 40% Higher This Week
Why Verve Therapeutics Is Skyrocketing Today
The Motley Fool • 15.04.25 • 16:43
Why Verve Therapeutics Is Skyrocketing Today

VERV Stock Price Chart

‎51.01‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Verve Therapeutics Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Verve Therapeutics Inc share price today is 4.48, reflecting a ‎6.16‎% change over the last 24 hours and ‎-18.28‎% over the past week. The current market capitalization of VERV is 399.36M with an average volume in the last three months of 2.84M. The stock has a P/E ratio of -1.91 and a dividend yield of 0%. With the stock’s beta sitting at 2
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
399.36M
Day’s Range
i
Shows the high and low prices of the day.
4.04 - 6.07
52W Range
i
Shows the high and low prices of the last year.
2.91 - 20.07
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.84M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-1.91
Revenue
i
The total income generated by this company’s goods and services last year.
32.33M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
4.48
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-2.35
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
2
What Is Verve Therapeutics Inc?
Verve Therapeutics Inc is an American biotechnology company primarily engaged in the development of single-course, in vivo, liver-directed gene editing medicines aimed at effectively treating cardiovascular disease. Established in 2018, the firm has its headquarters in Cambridge, Massachusetts, and serves clients across the USA and the world.

The firm has developed a number of strategic partnerships and collaborations with various influential industry leaders, including the Broad Institute, Harvard University and Acuitas Therapeutics, Inc. The firm is listed on the NASDAQ under the ticker VERV.

Track this instrument by adding it to your eToro watchlist and get instant updates on VERV price changes.
Buy VERV

How can I buy Verve Therapeutics Inc stocks?

To purchase Verve Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Verve Therapeutics Inc (VERV) page and place an order to buy Verve Therapeutics Inc.
Buy VERV
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Verve Therapeutics Inc
Invest in Verve Therapeutics Inc
Today
Create an eToro account to buy VERV stock on a secure, user-friendly, multi-asset trading platform.
Buy VERV

FAQ

The current price of VERV is 4.48.
The average price target for Verve Therapeutics Inc is 4.48. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Verve Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Verve Therapeutics Inc is 399.36M
Based on 3 analysts offering recommendations for VERV in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top